Ligand validation:6Q4O

LMT: DODECYL-BETA-D-MALTOSIDE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6Q4O_LMT_B_1102	40%	70%	0.211	0.923	0.45	0.69	-	1	1	0	100%	1
6Q4O_LMT_C_1101	35%	69%	0.246	0.935	0.48	0.72	1	-	0	0	100%	1
6Q4O_LMT_B_1103	20%	72%	0.301	0.906	0.47	0.62	1	-	0	0	100%	1
6Q4O_LMT_A_1102	19%	68%	0.234	0.827	0.52	0.72	1	1	0	0	100%	1
6Q4O_LMT_A_1104	12%	70%	0.348	0.877	0.5	0.66	-	-	0	0	100%	1
6Q4O_LMT_C_1102	3%	53%	0.385	0.722	0.63	1.19	1	7	0	0	100%	1
6Q4O_LMT_A_1101	1%	73%	0.463	0.684	0.48	0.58	-	-	0	0	100%	1
6Q4O_LMT_A_1103	1%	57%	0.407	0.618	0.55	1.08	-	5	0	0	100%	1
4U8Y_LMT_C_1101	83%	64%	0.096	0.953	0.43	0.92	-	1	2	0	100%	1
4U95_LMT_C_1101	69%	65%	0.121	0.935	0.43	0.9	-	2	2	0	100%	1
4DX5_LMT_C_1102	69%	42%	0.124	0.937	1.18	1.09	3	2	1	0	100%	1
4DX7_LMT_A_1101	69%	36%	0.131	0.944	1.24	1.26	4	6	3	0	100%	1
4U96_LMT_C_1101	64%	65%	0.137	0.937	0.44	0.9	-	1	0	0	100%	1
5NV9_LMT_A_504	99%	31%	0.045	0.983	0.57	2.12	-	12	1	0	100%	1
3CAY_LMT_A_512	94%	59%	0.071	0.968	0.66	0.9	-	1	0	0	100%	1
3SZF_LMT_A_501	73%	33%	0.101	0.928	1.23	1.44	3	5	2	0	100%	1
3T14_LMT_A_501	72%	31%	0.12	0.945	1.21	1.54	3	10	2	0	100%	1
5WS6_LMT_M_101	71%	58%	0.098	0.919	0.5	1.08	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.